FDA Head Von Eschenbach Resigning In January; Industry Awaits Successor
This article was originally published in The Rose Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, closing out a bumpy tenure marked by some notable successes
You may also be interested in...
With Democrat In White House, “More Aggressive” FDA Comes Into Focus
Democratic control of the White House, Senate and House brings the potential of a "more aggressive" FDA into sharp focus
FDA Gets $1 Million Increase For Cosmetics Oversight In Fiscal 2008
FDA has received a $1 million increase in funds for "the review of cosmetics" in fiscal year 2008 as part of an omnibus appropriations package signed by President Bush Dec. 26
Acting Commissioner Von Eschenbach Made Permanent In Time For New Year
Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle